News
-
-
-
-
-
-
-
-
-
PRESS RELEASE
Norgine announces European Commission Marketing Authorisation for XOLREMDI® (mavorixafor), the first authorised treatment for patients with WHIM syndrome in the European Union
Norgine receives EC authorization for XOLREMDI® for WHIM syndrome, the first treatment in the EU for this rare condition. Approval based on positive CHMP opinion and Phase 3 trial results -
PRESS RELEASE
Latvia's Minister of Economics Viktors Valainis Highlights Strategic Cooperation in Security, Technology and Energy at Latvia-Poland Business Forum
Latvia's Minister of Economics Viktors Valainis highlights strategic cooperation in security, technology, and energy at Latvia-Poland Business Forum